Featured Research

from universities, journals, and other organizations

Early detection of stomach cancer: New hope from new research

Date:
March 17, 2014
Source:
University of Adelaide
Summary:
New hope for the early detection of stomach cancer has been revealed with the identification of four new biomarkers in the blood of human cancer patients. Stomach or gastric cancer is the fourth most common cancer in the world and the second leading cause of death due to cancer. It is typically without symptoms, so is rarely caught in its early stages.

University of Adelaide research has provided new hope for the early detection of stomach cancer with the identification of four new biomarkers in the blood of human cancer patients.

Stomach or gastric cancer is the fourth most common cancer in the world and the second leading cause of death due to cancer.

“Stomach cancer is typically without symptoms in the early stages so most cancers are not diagnosed until the later stages, and the survival rates are therefore low,” says Associate Professor Peter Hoffmann, project leader and Director of the University’s Adelaide Proteomics Centre.

“Endoscopic investigations are invasive and expensive and most are generally not conducted until the cancer is at an advanced stage.

“A non-invasive, inexpensive screening technique through a simple blood test for the early detection of stomach cancer would make a huge difference in the survival outcomes for people with this disease.”

Published in journal Biochimica et Biophysica Acta, the researchers have identified four new proteins that change in concentration in the blood of stomach cancer patients.

In this latest research, conducted by Dr Julia Humphries who is now at SA Pathology and Dr Megan Penno, they showed differences in the four protein levels between serum samples from 37 gastric cancer patients, including 11 early stage cancer patients, and the controls which included healthy and non-cancerous patients with other gastric disease.

All four proteins – afamin, clusterin, haptoglobin and vitamin D binding protein (VDBP) – were individually superior to a current clinical marker CA72-4 in discriminating stomach cancer from healthy controls.

“Using the four markers together produces high levels of selectivity and sensitivity in detecting stomach cancer,” says Associate Professor Hoffmann.

The biomarkers are subject to a PCT (Provisional Cooperation Treaty) patent and commercial partners are being sought.

The research has been funded by the National Health and Medical Research Council and the Ludwig Institute for Cancer Research, and is in collaboration with Associate Professor Matthias Ernst of the Walter and Eliza Hall Institute of Medical Research.


Story Source:

The above story is based on materials provided by University of Adelaide. Note: Materials may be edited for content and length.


Journal Reference:

  1. Julia M. Humphries, Megan A.S. Penno, Florian Weiland, Manuela Klingler-Hoffmann, Agnieszka Zuber, Alex Boussioutas, Matthias Ernst, Peter Hoffmann. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2014; DOI: 10.1016/j.bbapap.2014.01.018

Cite This Page:

University of Adelaide. "Early detection of stomach cancer: New hope from new research." ScienceDaily. ScienceDaily, 17 March 2014. <www.sciencedaily.com/releases/2014/03/140317095839.htm>.
University of Adelaide. (2014, March 17). Early detection of stomach cancer: New hope from new research. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2014/03/140317095839.htm
University of Adelaide. "Early detection of stomach cancer: New hope from new research." ScienceDaily. www.sciencedaily.com/releases/2014/03/140317095839.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins